Monday February 3, 2020
UPDATE: National Density Reporting Standard
Senator Dianne Feinstein was the lead sponsor on federal legislation requiring the FDA to develop breast density reporting language to be included in patient letters and health provider reports. The FDA made public the proposed rule in March 2019, and we now wait to learn what the FDA’s final rule (scheduled for Sept 2020) and implementation period (proposed, 18 months) will be. We will keep you posted on our work on this important issue.
2020 Referring Community Reach Out
As it is most often to a referring provider that a woman addresses her “density” questions after a density notification, a DB-I 2020 priority is reaching referring providers to share our educational resource. For the first time, DB-I will have a booth at both NCoBC and ACOG, stop by to say hello!